Alphabet soup: A personal, evolving, mostly evidence-based and logical, sequential approach to the "ABCNR" drugs in multiple sclerosis

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

With the development of multiple options for immunotherapy in multiple sclerosis, the clinician is faced with the challenge of keeping pace with the literature, acquiring familiarity with the various treatment options and opinions, and then offering the patients the most current and appropriate management. Given the inherent nature of a multifocal and unpredictable disease such as multiple sclerosis, along with the availability of multiple treatment options, it behooves the clinician to develop an evidence-based rationale for how to best manage patients. This article reflects the common questions that arise from referring neurologists regarding my personal approach to the management of patients with multiple sclerosis.

Original languageEnglish
Pages (from-to)17-25
Number of pages9
JournalSeminars in Neurology
Volume22
Issue number1
StatePublished - 2002

Fingerprint

Multiple Sclerosis
Pharmaceutical Preparations
Immunotherapy
Therapeutics
Neurologists
Recognition (Psychology)

Keywords

  • Demyelinating disease
  • Immunotherapy
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

@article{9a68f885970d4de2b9fc392b8d6bdd29,
title = "Alphabet soup: A personal, evolving, mostly evidence-based and logical, sequential approach to the {"}ABCNR{"} drugs in multiple sclerosis",
abstract = "With the development of multiple options for immunotherapy in multiple sclerosis, the clinician is faced with the challenge of keeping pace with the literature, acquiring familiarity with the various treatment options and opinions, and then offering the patients the most current and appropriate management. Given the inherent nature of a multifocal and unpredictable disease such as multiple sclerosis, along with the availability of multiple treatment options, it behooves the clinician to develop an evidence-based rationale for how to best manage patients. This article reflects the common questions that arise from referring neurologists regarding my personal approach to the management of patients with multiple sclerosis.",
keywords = "Demyelinating disease, Immunotherapy, Multiple sclerosis",
author = "David Mattson",
year = "2002",
language = "English",
volume = "22",
pages = "17--25",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Alphabet soup

T2 - A personal, evolving, mostly evidence-based and logical, sequential approach to the "ABCNR" drugs in multiple sclerosis

AU - Mattson, David

PY - 2002

Y1 - 2002

N2 - With the development of multiple options for immunotherapy in multiple sclerosis, the clinician is faced with the challenge of keeping pace with the literature, acquiring familiarity with the various treatment options and opinions, and then offering the patients the most current and appropriate management. Given the inherent nature of a multifocal and unpredictable disease such as multiple sclerosis, along with the availability of multiple treatment options, it behooves the clinician to develop an evidence-based rationale for how to best manage patients. This article reflects the common questions that arise from referring neurologists regarding my personal approach to the management of patients with multiple sclerosis.

AB - With the development of multiple options for immunotherapy in multiple sclerosis, the clinician is faced with the challenge of keeping pace with the literature, acquiring familiarity with the various treatment options and opinions, and then offering the patients the most current and appropriate management. Given the inherent nature of a multifocal and unpredictable disease such as multiple sclerosis, along with the availability of multiple treatment options, it behooves the clinician to develop an evidence-based rationale for how to best manage patients. This article reflects the common questions that arise from referring neurologists regarding my personal approach to the management of patients with multiple sclerosis.

KW - Demyelinating disease

KW - Immunotherapy

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0036074771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036074771&partnerID=8YFLogxK

M3 - Article

C2 - 12170390

AN - SCOPUS:0036074771

VL - 22

SP - 17

EP - 25

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 1

ER -